Corticosteroid therapy in fibrotic interstitial lung disease: a modified delphi survey

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Conflict of interest: F.A.M, C.D, G.M are employees of ENA Respiratory Pty Ltd, receive an annual salary and other benefits. In addition, they have shares and share options and are named inventors on numerous granted or pending patent applications controlled by ENA.

Conflict of interest: Manuela Funke-Chambour declares consultancy and speaker's fees from Boehringer Ingelheim, Roche, MSD, Astra, Pfizer, GSK, and Sanofi, outside this project.

Conflict of interest: Philipp Suter has nothing to disclose.

Conflict of interest: R Gisli Jenkins declares grants to his institution from Astra Zeneca, Biogen, Galecto GlaxoSmithKline, Nordic, Biosciences, RedX, Pliant, consultancy fees from AbbVie, Apollo Therapeutics, Astra Zeneca, Brainomix, Bristol Myers Squibb, Chiesi, Cohbar, Daewoong, GlaxoSmithKline, Resolution Therapeutics, Pliant, honoraria from Boehringer Ingelheim, Chiesi, Roche, PatientMPower, AstraZeneca, payment for expert testimony from Pinsent Masons LLP, and participation on data safety or advisory board for Boehringer Ingelheim, Galapagos, Vicore, outside this project.

Conflict of interest: Leticia Kawano-Dourado declares grants payed to the institution from Boehringer Ingelheim, Bristol Myers Squibb, and consultancy fees from Boehringer Ingelheim, outside this project.

Conflict of interest: Christopher J Ryerson declares grants from Boehringer Ingelheim payed to his institution, consultancy fees from Boehringer Ingelheim, Pliant Therapeutics, Astra Zeneca, Trevi Therapeutics, Veracyte, Payment or honoraria for lectures, presentations from Hoffmann-La Roche, Boehringer Ingelheim, Payment for expert testimony, Payment for expert testimony and travel support from Boehringer Ingelheim, outside this project.

Conflict of interest: Athol U Wells reports consultancy fees from Roche, Payment or honoraria for lectures, presentations, from Boehringer Ingelheim, Veracyte, Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid as President of World Association of Sarcoidosis and other granulomatous diseases, outside of the submitted work.

Conflict of interest: Michael Kreuter declares grants or contracts from any entity and Royalties or licenses from Boehringer Ingelheim, Roche, Consulting fees from Nichtraucherhelden/Sanero, Boehringer Ingelheim, Roche, BMS, GSK, AstraZeneca, Leadership or fiduciary role in other board, society committee or advocacy group, paid or unpaid at ERS, outside this project.